

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.39297917 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.30190533 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.05242540 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.05242540 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.05242540 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.05242540 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.05242540 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.05242540 |
| 9 | neuronal action potential propagation (GO:0019227) | 4.87926602 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.70048325 |
| 11 | detection of other organism (GO:0098543) | 4.61521878 |
| 12 | detection of bacterium (GO:0016045) | 4.57601648 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.56680501 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.51339090 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.34035051 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.18512230 |
| 17 | glutamate secretion (GO:0014047) | 4.13695042 |
| 18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.13530125 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.04269620 |
| 20 | leukocyte aggregation (GO:0070486) | 4.02826765 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.01755220 |
| 22 | locomotory exploration behavior (GO:0035641) | 3.85636680 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.82337098 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81893305 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.80753194 |
| 26 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.78806628 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 3.76505837 |
| 28 | neutrophil activation (GO:0042119) | 3.76113041 |
| 29 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.74783217 |
| 30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.72273792 |
| 31 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.65792346 |
| 32 | response to peptidoglycan (GO:0032494) | 3.62093320 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61865554 |
| 34 | sodium ion export (GO:0071436) | 3.59321280 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58069168 |
| 36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.58007817 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.51107335 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.50928759 |
| 39 | respiratory burst (GO:0045730) | 3.47426308 |
| 40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.47002436 |
| 41 | cellular extravasation (GO:0045123) | 3.46484568 |
| 42 | response to host immune response (GO:0052572) | 3.45953500 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45953500 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.44722921 |
| 45 | positive thymic T cell selection (GO:0045059) | 3.43111632 |
| 46 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.38828679 |
| 47 | granulocyte activation (GO:0036230) | 3.38514309 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.38034847 |
| 49 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33575868 |
| 50 | vocalization behavior (GO:0071625) | 3.32301265 |
| 51 | detection of molecule of bacterial origin (GO:0032490) | 3.31827674 |
| 52 | microglial cell activation (GO:0001774) | 3.31624934 |
| 53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.29655468 |
| 54 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.29193510 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.29186080 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.28814368 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.28645793 |
| 58 | neurotransmitter secretion (GO:0007269) | 3.27833499 |
| 59 | cellular potassium ion homeostasis (GO:0030007) | 3.26831626 |
| 60 | detection of biotic stimulus (GO:0009595) | 3.25997465 |
| 61 | protein localization to synapse (GO:0035418) | 3.23766256 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18607118 |
| 63 | response to host (GO:0075136) | 3.18607118 |
| 64 | response to host defenses (GO:0052200) | 3.18607118 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.18362328 |
| 66 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18299929 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18055546 |
| 68 | activation of protein kinase A activity (GO:0034199) | 3.16781479 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 3.15835038 |
| 70 | macrophage activation (GO:0042116) | 3.15045259 |
| 71 | germinal center formation (GO:0002467) | 3.14187113 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.12057447 |
| 73 | regulation of synapse structural plasticity (GO:0051823) | 3.11346515 |
| 74 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10438510 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 3.09514358 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 3.09255566 |
| 77 | signal complex assembly (GO:0007172) | 3.07732192 |
| 78 | regulation of B cell differentiation (GO:0045577) | 3.07497165 |
| 79 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.06769760 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.05249040 |
| 81 | negative regulation of cell killing (GO:0031342) | 3.04917661 |
| 82 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04917661 |
| 83 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.04346885 |
| 84 | type I interferon signaling pathway (GO:0060337) | 3.03948687 |
| 85 | cellular response to type I interferon (GO:0071357) | 3.03948687 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 3.03227287 |
| 87 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.03169793 |
| 88 | response to type I interferon (GO:0034340) | 3.03140515 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 3.01696301 |
| 90 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.01679037 |
| 91 | response to muramyl dipeptide (GO:0032495) | 3.00760553 |
| 92 | negative T cell selection (GO:0043383) | 3.00758923 |
| 93 | positive regulation of Rap GTPase activity (GO:0032854) | 2.99981100 |
| 94 | regulation of ARF protein signal transduction (GO:0032012) | 2.97411929 |
| 95 | tolerance induction (GO:0002507) | 2.95883562 |
| 96 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94757592 |
| 97 | long-term memory (GO:0007616) | 2.94348758 |
| 98 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93750583 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92690905 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92690905 |
| 101 | exploration behavior (GO:0035640) | 2.92617987 |
| 102 | leukocyte degranulation (GO:0043299) | 2.92373482 |
| 103 | positive regulation of B cell differentiation (GO:0045579) | 2.91731901 |
| 104 | positive regulation of membrane potential (GO:0045838) | 2.90424493 |
| 105 | defense response to protozoan (GO:0042832) | 2.89947332 |
| 106 | thymic T cell selection (GO:0045061) | 2.89609773 |
| 107 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.89043479 |
| 108 | T cell selection (GO:0045058) | 2.88071067 |
| 109 | positive T cell selection (GO:0043368) | 2.87135104 |
| 110 | regulation of tolerance induction (GO:0002643) | 2.85475356 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.85384456 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84270192 |
| 113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83444566 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82217174 |
| 115 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.81530177 |
| 116 | regulation of mast cell activation (GO:0033003) | 2.80383792 |
| 117 | synaptic transmission, glutamatergic (GO:0035249) | 2.78436759 |
| 118 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77572989 |
| 119 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77572989 |
| 120 | negative regulation of innate immune response (GO:0045824) | 2.77440776 |
| 121 | membrane depolarization during action potential (GO:0086010) | 2.77225516 |
| 122 | activated T cell proliferation (GO:0050798) | 2.74786843 |
| 123 | glutamate receptor signaling pathway (GO:0007215) | 2.74637656 |
| 124 | potassium ion import (GO:0010107) | 2.74008137 |
| 125 | regulation of vesicle fusion (GO:0031338) | 2.73947548 |
| 126 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.71375852 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70556843 |
| 128 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.70394023 |
| 129 | glycine transport (GO:0015816) | 2.69228214 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.68512775 |
| 131 | positive regulation of mast cell degranulation (GO:0043306) | 2.68512775 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65731482 |
| 133 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65255675 |
| 134 | regulation of neurotransmitter secretion (GO:0046928) | 2.64982373 |
| 135 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.64569672 |
| 136 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.63291801 |
| 137 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.62943249 |
| 138 | gamma-aminobutyric acid transport (GO:0015812) | 2.60632632 |
| 139 | neurotransmitter transport (GO:0006836) | 2.60049719 |
| 140 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.59607707 |
| 141 | neuron-neuron synaptic transmission (GO:0007270) | 2.55785271 |
| 142 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.53721749 |
| 143 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.53721749 |
| 144 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.53350870 |
| 145 | Peyers patch development (GO:0048541) | 2.53350870 |
| 146 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51394994 |
| 147 | regulation of neurotransmitter levels (GO:0001505) | 2.48884936 |
| 148 | regulation of synaptic plasticity (GO:0048167) | 2.48267351 |
| 149 | regulation of neuron projection regeneration (GO:0070570) | 2.46811186 |
| 150 | regulation of axon regeneration (GO:0048679) | 2.46811186 |
| 151 | positive regulation of catecholamine secretion (GO:0033605) | 2.45292174 |
| 152 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.43680656 |
| 153 | neuron cell-cell adhesion (GO:0007158) | 2.42930916 |
| 154 | regulation of postsynaptic membrane potential (GO:0060078) | 2.42762051 |
| 155 | regulation of neurotransmitter transport (GO:0051588) | 2.40002949 |
| 156 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.39979915 |
| 157 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.39979915 |
| 158 | membrane depolarization (GO:0051899) | 2.39807164 |
| 159 | layer formation in cerebral cortex (GO:0021819) | 2.38309424 |
| 160 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.37886545 |
| 161 | regulation of regulatory T cell differentiation (GO:0045589) | 2.37808109 |
| 162 | regulation of beta-amyloid formation (GO:1902003) | 2.37299394 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.36909140 |
| 164 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.36500820 |
| 165 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.36328321 |
| 166 | adult walking behavior (GO:0007628) | 2.36017856 |
| 167 | cellular sodium ion homeostasis (GO:0006883) | 2.35856948 |
| 168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.35709885 |
| 169 | cell communication by electrical coupling (GO:0010644) | 2.33302785 |
| 170 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.32349862 |
| 171 | positive regulation of vesicle fusion (GO:0031340) | 2.32278522 |
| 172 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.30621068 |
| 173 | long-term synaptic potentiation (GO:0060291) | 2.30003795 |
| 174 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.28365813 |
| 175 | suckling behavior (GO:0001967) | 2.26971091 |
| 176 | negative regulation of type 2 immune response (GO:0002829) | 2.26949511 |
| 177 | synaptic vesicle endocytosis (GO:0048488) | 2.26540990 |
| 178 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.26499208 |
| 179 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.26499208 |
| 180 | positive regulation of neurotransmitter transport (GO:0051590) | 2.25933427 |
| 181 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.25652537 |
| 182 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.24764367 |
| 183 | calcium ion-dependent exocytosis (GO:0017156) | 2.23470810 |
| 184 | response to interleukin-15 (GO:0070672) | 2.23262971 |
| 185 | detection of calcium ion (GO:0005513) | 2.22714007 |
| 186 | regulation of ARF GTPase activity (GO:0032312) | 2.22339416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75785399 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.83094934 |
| 3 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.96452593 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62891819 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.44558887 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37772596 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36196167 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.34515321 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.29489291 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.26742220 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25823420 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.25121983 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.23468856 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22559297 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18068294 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17937961 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13861768 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13861768 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.12498598 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09572652 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06497409 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01034383 |
| 23 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00268476 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97515292 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95326348 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93766313 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92416223 |
| 28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92203375 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.90438369 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87580939 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.81549412 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80725380 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80687511 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.79000294 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77306711 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.77189294 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74851229 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72696983 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.72531628 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70301109 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.69716633 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68736376 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67315008 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64441862 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63337545 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.62861856 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61910141 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59614071 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57847940 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56110555 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55135388 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54704997 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.52778234 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52614703 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49413442 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47695431 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46683823 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46428746 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46285023 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43335530 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41585405 |
| 62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40148524 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36641987 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34847347 |
| 65 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33654562 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32985086 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30520906 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30454647 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30188893 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29674909 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28467082 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26486290 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24284198 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23923052 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23812188 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23034476 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22185353 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21470591 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21102538 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19998229 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19575788 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18976385 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18878221 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17775583 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17066829 |
| 86 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15707985 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15271410 |
| 88 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14760483 |
| 89 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.13400525 |
| 90 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.13369604 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13292023 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12995946 |
| 93 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12605843 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11151573 |
| 95 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11018357 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.09306209 |
| 97 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08406091 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06648498 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05623233 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04862541 |
| 101 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03360276 |
| 102 | MYC_22102868_ChIP-Seq_BL_Human | 1.02676460 |
| 103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02560998 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02108407 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01874813 |
| 106 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00906041 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00856543 |
| 108 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.00452843 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00436027 |
| 110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99903419 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98079448 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97193685 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96787203 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96312502 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94252363 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94096472 |
| 117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94041312 |
| 118 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93050811 |
| 119 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92844312 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92193123 |
| 121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91697598 |
| 122 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91092797 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.88974893 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88760926 |
| 125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88659305 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88058054 |
| 127 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.87483426 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86796188 |
| 129 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86530815 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86198224 |
| 131 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85727440 |
| 132 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85204856 |
| 133 | P68_20966046_ChIP-Seq_HELA_Human | 0.83718134 |
| 134 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82760032 |
| 135 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.82091682 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81856257 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81727947 |
| 138 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.78090104 |
| 139 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.76962787 |
| 140 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76893863 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76696918 |
| 142 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.76630600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.24220865 |
| 2 | MP0003724_increased_susceptibility_to | 4.48795086 |
| 3 | MP0003436_decreased_susceptibility_to | 4.06316629 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.28041406 |
| 5 | MP0003880_abnormal_central_pattern | 3.22449182 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.13409768 |
| 7 | MP0004270_analgesia | 3.06181793 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.85543957 |
| 9 | MP0002419_abnormal_innate_immunity | 2.78533661 |
| 10 | MP0009745_abnormal_behavioral_response | 2.59914386 |
| 11 | MP0002064_seizures | 2.51897870 |
| 12 | MP0002736_abnormal_nociception_after | 2.51571953 |
| 13 | MP0002272_abnormal_nervous_system | 2.35479615 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.35374820 |
| 15 | MP0008569_lethality_at_weaning | 2.32909588 |
| 16 | MP0006082_CNS_inflammation | 2.18565795 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.17755867 |
| 18 | MP0008260_abnormal_autophagy | 2.17626646 |
| 19 | MP0009046_muscle_twitch | 2.14246462 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.09819201 |
| 21 | MP0001970_abnormal_pain_threshold | 2.08560832 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.08537614 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.04135735 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.04073264 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.01431232 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.98824290 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.98263341 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.94461023 |
| 29 | MP0003879_abnormal_hair_cell | 1.92428254 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.92357212 |
| 31 | MP0004510_myositis | 1.92267173 |
| 32 | MP0002132_abnormal_respiratory_system | 1.88026427 |
| 33 | MP0002405_respiratory_system_inflammati | 1.80594848 |
| 34 | MP0009278_abnormal_bone_marrow | 1.80446777 |
| 35 | MP0002822_catalepsy | 1.78938467 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.77326738 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.71659068 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.69835464 |
| 39 | MP0003329_amyloid_beta_deposits | 1.66333285 |
| 40 | MP0001486_abnormal_startle_reflex | 1.64849170 |
| 41 | MP0004858_abnormal_nervous_system | 1.60822346 |
| 42 | MP0003690_abnormal_glial_cell | 1.60402111 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.59117652 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.57524743 |
| 45 | MP0004947_skin_inflammation | 1.54140818 |
| 46 | MP0004147_increased_porphyrin_level | 1.51493879 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.50052908 |
| 48 | MP0004381_abnormal_hair_follicle | 1.48077138 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.47439465 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.46320324 |
| 51 | MP0001984_abnormal_olfaction | 1.45770537 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.45103332 |
| 53 | MP0000685_abnormal_immune_system | 1.43927003 |
| 54 | MP0005671_abnormal_response_to | 1.43175181 |
| 55 | MP0008874_decreased_physiological_sensi | 1.42409487 |
| 56 | MP0003633_abnormal_nervous_system | 1.42322477 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.41995238 |
| 58 | MP0002722_abnormal_immune_system | 1.40816663 |
| 59 | MP0002429_abnormal_blood_cell | 1.36080953 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.36043135 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.34551725 |
| 62 | MP0005451_abnormal_body_composition | 1.32299887 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.32270390 |
| 64 | MP0003828_pulmonary_edema | 1.31764395 |
| 65 | MP0001851_eye_inflammation | 1.30831099 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.29240717 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.28714136 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.28486986 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.28100646 |
| 70 | MP0004142_abnormal_muscle_tone | 1.27347704 |
| 71 | MP0003866_abnormal_defecation | 1.24647775 |
| 72 | MP0002184_abnormal_innervation | 1.24172205 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.22505915 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.21916952 |
| 75 | MP0000920_abnormal_myelination | 1.19122494 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 1.19110052 |
| 77 | MP0008469_abnormal_protein_level | 1.18622257 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.18277615 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.18277615 |
| 80 | MP0003075_altered_response_to | 1.17583657 |
| 81 | MP0001905_abnormal_dopamine_level | 1.15459810 |
| 82 | MP0009764_decreased_sensitivity_to | 1.14146145 |
| 83 | MP0000955_abnormal_spinal_cord | 1.11087171 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.10552510 |
| 85 | MP0005386_behavior/neurological_phenoty | 1.09967151 |
| 86 | MP0004924_abnormal_behavior | 1.09967151 |
| 87 | MP0004130_abnormal_muscle_cell | 1.09516132 |
| 88 | MP0004883_abnormal_blood_vessel | 1.09207443 |
| 89 | MP0001790_abnormal_immune_system | 1.09182664 |
| 90 | MP0005387_immune_system_phenotype | 1.09182664 |
| 91 | MP0005535_abnormal_body_temperature | 1.08007458 |
| 92 | MP0000751_myopathy | 1.07174152 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.06109526 |
| 94 | MP0002998_abnormal_bone_remodeling | 1.05916578 |
| 95 | MP0005646_abnormal_pituitary_gland | 0.97927402 |
| 96 | MP0001800_abnormal_humoral_immune | 0.97445795 |
| 97 | MP0001835_abnormal_antigen_presentation | 0.96381027 |
| 98 | MP0002882_abnormal_neuron_morphology | 0.95992468 |
| 99 | MP0001873_stomach_inflammation | 0.95855866 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.95680771 |
| 101 | MP0002229_neurodegeneration | 0.95039166 |
| 102 | MP0003045_fibrosis | 0.94193953 |
| 103 | MP0000747_muscle_weakness | 0.93898087 |
| 104 | MP0008004_abnormal_stomach_pH | 0.93614435 |
| 105 | MP0004885_abnormal_endolymph | 0.93604734 |
| 106 | MP0002933_joint_inflammation | 0.92119259 |
| 107 | MP0000858_altered_metastatic_potential | 0.91577531 |
| 108 | MP0009785_altered_susceptibility_to | 0.91109598 |
| 109 | MP0002420_abnormal_adaptive_immunity | 0.90664837 |
| 110 | MP0003631_nervous_system_phenotype | 0.89625853 |
| 111 | MP0008872_abnormal_physiological_respon | 0.89065052 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.88719802 |
| 113 | MP0001819_abnormal_immune_cell | 0.87544680 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.87474465 |
| 115 | MP0002723_abnormal_immune_serum | 0.87266122 |
| 116 | MP0002398_abnormal_bone_marrow | 0.86511975 |
| 117 | MP0005310_abnormal_salivary_gland | 0.84786505 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.83742171 |
| 119 | MP0001663_abnormal_digestive_system | 0.83546726 |
| 120 | MP0003878_abnormal_ear_physiology | 0.82856929 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.82856929 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.82424214 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.80554034 |
| 124 | MP0000604_amyloidosis | 0.80294706 |
| 125 | MP0005390_skeleton_phenotype | 0.80169065 |
| 126 | MP0010234_abnormal_vibrissa_follicle | 0.78899747 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.78331624 |
| 128 | MP0004484_altered_response_of | 0.77759239 |
| 129 | MP0002653_abnormal_ependyma_morphology | 0.77720578 |
| 130 | MP0005025_abnormal_response_to | 0.77102030 |
| 131 | MP0005083_abnormal_biliary_tract | 0.76904984 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.76486071 |
| 133 | MP0003646_muscle_fatigue | 0.76086378 |
| 134 | MP0005164_abnormal_response_to | 0.75854601 |
| 135 | MP0000716_abnormal_immune_system | 0.74816104 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.72377014 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.71947220 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.71825479 |
| 139 | MP0003191_abnormal_cellular_cholesterol | 0.71430821 |
| 140 | MP0003787_abnormal_imprinting | 0.71150347 |
| 141 | MP0001664_abnormal_digestion | 0.70967428 |
| 142 | MP0005166_decreased_susceptibility_to | 0.69422217 |
| 143 | MP0002452_abnormal_antigen_presenting | 0.69009906 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.66260257 |
| 145 | MP0000343_altered_response_to | 0.65382894 |
| 146 | MP0004085_abnormal_heartbeat | 0.65306194 |
| 147 | MP0003303_peritoneal_inflammation | 0.64641737 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64349006 |
| 149 | MP0000249_abnormal_blood_vessel | 0.59685040 |
| 150 | MP0009763_increased_sensitivity_to | 0.59054557 |
| 151 | MP0005388_respiratory_system_phenotype | 0.58817136 |
| 152 | MP0002133_abnormal_respiratory_system | 0.58817136 |
| 153 | MP0001958_emphysema | 0.58629426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.29254012 |
| 2 | Myokymia (HP:0002411) | 5.88961451 |
| 3 | Myositis (HP:0100614) | 5.30910640 |
| 4 | Focal motor seizures (HP:0011153) | 5.20759993 |
| 5 | Visual hallucinations (HP:0002367) | 5.12698096 |
| 6 | Recurrent abscess formation (HP:0002722) | 5.09054175 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.00785926 |
| 8 | Orchitis (HP:0100796) | 4.80429390 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 4.71832369 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.61977460 |
| 11 | Febrile seizures (HP:0002373) | 4.45623940 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.38745013 |
| 13 | Optic neuritis (HP:0100653) | 4.38745013 |
| 14 | Stomatitis (HP:0010280) | 4.31113413 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.27689280 |
| 16 | Focal seizures (HP:0007359) | 4.19028809 |
| 17 | Atonic seizures (HP:0010819) | 4.05691388 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.00417809 |
| 19 | Obstructive lung disease (HP:0006536) | 4.00417809 |
| 20 | Meningitis (HP:0001287) | 3.89172056 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.86765047 |
| 22 | Hypochromic anemia (HP:0001931) | 3.81708176 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.74799706 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.72822468 |
| 25 | Increased IgE level (HP:0003212) | 3.69720140 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.69673861 |
| 27 | Epileptic encephalopathy (HP:0200134) | 3.47950512 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.43470996 |
| 29 | Cellulitis (HP:0100658) | 3.41725421 |
| 30 | Encephalitis (HP:0002383) | 3.39574904 |
| 31 | Action tremor (HP:0002345) | 3.38189395 |
| 32 | Recurrent skin infections (HP:0001581) | 3.36215299 |
| 33 | Vasculitis (HP:0002633) | 3.21926543 |
| 34 | Urticaria (HP:0001025) | 3.21492669 |
| 35 | Depression (HP:0000716) | 3.18263635 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.17160580 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 3.15758488 |
| 38 | Gingivitis (HP:0000230) | 3.10618312 |
| 39 | Episodic fever (HP:0001954) | 3.02379657 |
| 40 | Chest pain (HP:0100749) | 2.99425174 |
| 41 | Anxiety (HP:0000739) | 2.99202592 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99060394 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99060394 |
| 44 | Progressive inability to walk (HP:0002505) | 2.97305643 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.94062739 |
| 46 | Ankle clonus (HP:0011448) | 2.90713428 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.81975155 |
| 48 | Scanning speech (HP:0002168) | 2.81539777 |
| 49 | Absence seizures (HP:0002121) | 2.77978254 |
| 50 | Microcytic anemia (HP:0001935) | 2.77918125 |
| 51 | Truncal ataxia (HP:0002078) | 2.75750860 |
| 52 | Papilledema (HP:0001085) | 2.66450192 |
| 53 | Pustule (HP:0200039) | 2.65874516 |
| 54 | Dysmetria (HP:0001310) | 2.64275187 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.64008471 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.63205901 |
| 57 | Chronic otitis media (HP:0000389) | 2.62150936 |
| 58 | Agammaglobulinemia (HP:0004432) | 2.61893658 |
| 59 | Psychosis (HP:0000709) | 2.61543618 |
| 60 | Epistaxis (HP:0000421) | 2.61038536 |
| 61 | Hypercortisolism (HP:0001578) | 2.60879764 |
| 62 | Postural instability (HP:0002172) | 2.59602926 |
| 63 | Generalized tonic-clonic seizures (HP:0002069) | 2.59257059 |
| 64 | Gingival bleeding (HP:0000225) | 2.57782031 |
| 65 | Hemoptysis (HP:0002105) | 2.56567626 |
| 66 | Dialeptic seizures (HP:0011146) | 2.54333773 |
| 67 | Pulmonary embolism (HP:0002204) | 2.53241141 |
| 68 | T lymphocytopenia (HP:0005403) | 2.50138898 |
| 69 | Leukocytosis (HP:0001974) | 2.48288741 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.45960677 |
| 71 | Slow saccadic eye movements (HP:0000514) | 2.42115742 |
| 72 | Poor eye contact (HP:0000817) | 2.41490484 |
| 73 | Peritonitis (HP:0002586) | 2.40821506 |
| 74 | Petechiae (HP:0000967) | 2.39929464 |
| 75 | Amyloidosis (HP:0011034) | 2.39190991 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.38271914 |
| 77 | Osteomyelitis (HP:0002754) | 2.36746198 |
| 78 | Granulocytopenia (HP:0001913) | 2.35807485 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35583543 |
| 80 | Abnormal social behavior (HP:0012433) | 2.35397738 |
| 81 | Impaired social interactions (HP:0000735) | 2.35397738 |
| 82 | Growth hormone excess (HP:0000845) | 2.33895093 |
| 83 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.33802618 |
| 84 | Hypothermia (HP:0002045) | 2.33219312 |
| 85 | Purpura (HP:0000979) | 2.32838131 |
| 86 | Sepsis (HP:0100806) | 2.32608688 |
| 87 | Myotonia (HP:0002486) | 2.30216489 |
| 88 | Recurrent viral infections (HP:0004429) | 2.29836418 |
| 89 | Spinal canal stenosis (HP:0003416) | 2.29712109 |
| 90 | Obstructive sleep apnea (HP:0002870) | 2.28682459 |
| 91 | Focal dystonia (HP:0004373) | 2.26786019 |
| 92 | Papilloma (HP:0012740) | 2.26223277 |
| 93 | Verrucae (HP:0200043) | 2.26223277 |
| 94 | Panhypogammaglobulinemia (HP:0003139) | 2.24350338 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 2.24283042 |
| 96 | Torticollis (HP:0000473) | 2.23573997 |
| 97 | Abnormal eating behavior (HP:0100738) | 2.23531048 |
| 98 | Colitis (HP:0002583) | 2.23442574 |
| 99 | Arterial thrombosis (HP:0004420) | 2.21777805 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.20416963 |
| 101 | Abnormality of T cells (HP:0002843) | 2.20217488 |
| 102 | Status epilepticus (HP:0002133) | 2.20188283 |
| 103 | Lymphopenia (HP:0001888) | 2.19805447 |
| 104 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19069094 |
| 105 | Anorexia (HP:0002039) | 2.18405321 |
| 106 | Chronic sinusitis (HP:0011109) | 2.17936087 |
| 107 | Increased IgM level (HP:0003496) | 2.17203380 |
| 108 | Broad-based gait (HP:0002136) | 2.14788151 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 2.14051756 |
| 110 | Craniofacial dystonia (HP:0012179) | 2.10785392 |
| 111 | Agitation (HP:0000713) | 2.10457099 |
| 112 | Dysdiadochokinesis (HP:0002075) | 2.10050433 |
| 113 | Intention tremor (HP:0002080) | 2.08265056 |
| 114 | Exercise-induced myalgia (HP:0003738) | 2.08127785 |
| 115 | Rapidly progressive (HP:0003678) | 2.07944557 |
| 116 | Rigidity (HP:0002063) | 2.07134035 |
| 117 | Diplopia (HP:0000651) | 2.07063756 |
| 118 | Abnormality of binocular vision (HP:0011514) | 2.07063756 |
| 119 | Hemiplegia (HP:0002301) | 2.06595433 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 2.06036551 |
| 121 | Vertigo (HP:0002321) | 2.04933437 |
| 122 | Nasal polyposis (HP:0100582) | 2.04842547 |
| 123 | Mutism (HP:0002300) | 2.04660100 |
| 124 | Bradykinesia (HP:0002067) | 2.02613584 |
| 125 | Abnormality of the pleura (HP:0002103) | 2.02104310 |
| 126 | Annular pancreas (HP:0001734) | 2.02076180 |
| 127 | Acne (HP:0001061) | 2.01515393 |
| 128 | Loss of speech (HP:0002371) | 2.01441834 |
| 129 | Neuroendocrine neoplasm (HP:0100634) | 2.00761251 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 2.00700459 |
| 131 | Retinal dysplasia (HP:0007973) | 2.00204503 |
| 132 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98357776 |
| 133 | Nonprogressive disorder (HP:0003680) | 1.97774855 |
| 134 | Menstrual irregularities (HP:0000858) | 1.97539205 |
| 135 | Impaired smooth pursuit (HP:0007772) | 1.97180329 |
| 136 | Decreased circulating renin level (HP:0003351) | 1.97023107 |
| 137 | Difficulty running (HP:0009046) | 1.95727296 |
| 138 | Delusions (HP:0000746) | 1.95091944 |
| 139 | Polycythemia (HP:0001901) | 1.94982478 |
| 140 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.94779164 |
| 141 | Stereotypic behavior (HP:0000733) | 1.94177338 |
| 142 | Adrenal overactivity (HP:0002717) | 1.94049941 |
| 143 | Insomnia (HP:0100785) | 1.93697917 |
| 144 | Spastic gait (HP:0002064) | 1.93456519 |
| 145 | Amblyopia (HP:0000646) | 1.93407429 |
| 146 | Inability to walk (HP:0002540) | 1.93169345 |
| 147 | Urinary urgency (HP:0000012) | 1.91298416 |
| 148 | Abnormality of the peritoneum (HP:0002585) | 1.91152331 |
| 149 | Bundle branch block (HP:0011710) | 1.88698994 |
| 150 | Premature loss of primary teeth (HP:0006323) | 1.87566729 |
| 151 | Eosinophilia (HP:0001880) | 1.87390807 |
| 152 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.86324380 |
| 153 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.86258954 |
| 154 | Restrictive lung disease (HP:0002091) | 1.83402395 |
| 155 | Abnormality of the endocardium (HP:0004306) | 1.83315282 |
| 156 | IgM deficiency (HP:0002850) | 1.83088179 |
| 157 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82773099 |
| 158 | Gangrene (HP:0100758) | 1.82691186 |
| 159 | Skin ulcer (HP:0200042) | 1.81548999 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 1.79957786 |
| 161 | Poikilocytosis (HP:0004447) | 1.79450699 |
| 162 | Bronchitis (HP:0012387) | 1.78601638 |
| 163 | Glomerulopathy (HP:0100820) | 1.77333427 |
| 164 | Progressive microcephaly (HP:0000253) | 1.76782598 |
| 165 | Abnormality of the pericardium (HP:0001697) | 1.76593337 |
| 166 | Oligomenorrhea (HP:0000876) | 1.75980319 |
| 167 | Erythema (HP:0010783) | 1.75922083 |
| 168 | Abnormality of magnesium homeostasis (HP:0004921) | 1.75397887 |
| 169 | Pheochromocytoma (HP:0002666) | 1.74086514 |
| 170 | Neurofibrillary tangles (HP:0002185) | 1.73460265 |
| 171 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.72276665 |
| 172 | Deep palmar crease (HP:0006191) | 1.72099494 |
| 173 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69940987 |
| 174 | Failure to thrive in infancy (HP:0001531) | 1.69779229 |
| 175 | Limb dystonia (HP:0002451) | 1.68917970 |
| 176 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.68770663 |
| 177 | Peripheral hypomyelination (HP:0007182) | 1.67289760 |
| 178 | Abnormality of saccadic eye movements (HP:0000570) | 1.67277413 |
| 179 | Gastrointestinal inflammation (HP:0004386) | 1.65593317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.07505255 |
| 2 | NTRK3 | 2.85513298 |
| 3 | RIPK4 | 2.84302402 |
| 4 | MAP3K9 | 2.80729036 |
| 5 | IRAK4 | 2.44995086 |
| 6 | CDK19 | 2.43216369 |
| 7 | ARAF | 2.43137787 |
| 8 | KSR2 | 2.34309531 |
| 9 | BLK | 2.29236534 |
| 10 | CSK | 2.07050696 |
| 11 | DAPK2 | 2.03032059 |
| 12 | CAMKK2 | 1.98730992 |
| 13 | SIK2 | 1.94060027 |
| 14 | MAP4K1 | 1.89856076 |
| 15 | GRK5 | 1.88691250 |
| 16 | PINK1 | 1.87016324 |
| 17 | EPHB1 | 1.83604919 |
| 18 | MAP3K13 | 1.83013389 |
| 19 | EPHA4 | 1.81876813 |
| 20 | MAP2K7 | 1.75492366 |
| 21 | TNIK | 1.67997186 |
| 22 | FES | 1.55983244 |
| 23 | CAMKK1 | 1.54608325 |
| 24 | MAP2K4 | 1.51377488 |
| 25 | MAPKAPK3 | 1.50420548 |
| 26 | MAP3K3 | 1.49203724 |
| 27 | TNK2 | 1.47840310 |
| 28 | MAP3K2 | 1.46998975 |
| 29 | NTRK1 | 1.44113039 |
| 30 | MINK1 | 1.40888075 |
| 31 | MAP3K1 | 1.39549793 |
| 32 | CAMK1 | 1.34490101 |
| 33 | JAK3 | 1.31355340 |
| 34 | SYK | 1.28654559 |
| 35 | TAOK1 | 1.28093596 |
| 36 | NTRK2 | 1.22420731 |
| 37 | MAP3K4 | 1.22153843 |
| 38 | FGR | 1.20057523 |
| 39 | DAPK1 | 1.18774350 |
| 40 | PRPF4B | 1.16164220 |
| 41 | SIK3 | 1.16149464 |
| 42 | TAOK3 | 1.13271300 |
| 43 | PRKCH | 1.12619727 |
| 44 | MARK3 | 1.12027181 |
| 45 | MARK2 | 1.10547006 |
| 46 | GRK6 | 1.09540807 |
| 47 | ZAP70 | 1.06352713 |
| 48 | RET | 1.06228646 |
| 49 | MUSK | 1.04423643 |
| 50 | HIPK2 | 1.04215451 |
| 51 | LYN | 1.03769414 |
| 52 | PAK6 | 1.03342391 |
| 53 | EEF2K | 1.03321088 |
| 54 | CDK5 | 0.99370505 |
| 55 | RAF1 | 0.99071974 |
| 56 | PDK1 | 0.98716929 |
| 57 | SIK1 | 0.93337064 |
| 58 | MAP3K7 | 0.90240473 |
| 59 | TAOK2 | 0.90223874 |
| 60 | PHKG2 | 0.88281881 |
| 61 | PHKG1 | 0.88281881 |
| 62 | IKBKE | 0.86032800 |
| 63 | MAPK13 | 0.85933304 |
| 64 | PTK6 | 0.84751190 |
| 65 | TRIB3 | 0.84170369 |
| 66 | UHMK1 | 0.83378145 |
| 67 | PDPK1 | 0.82942347 |
| 68 | RIPK1 | 0.82369804 |
| 69 | ADRBK2 | 0.81858069 |
| 70 | SGK223 | 0.81564493 |
| 71 | SGK494 | 0.81564493 |
| 72 | MAP3K14 | 0.79895808 |
| 73 | DYRK1B | 0.79363325 |
| 74 | STK38 | 0.78660204 |
| 75 | MAPKAPK5 | 0.78262989 |
| 76 | IRAK2 | 0.77845195 |
| 77 | MAPK12 | 0.76552421 |
| 78 | MAP2K6 | 0.74498759 |
| 79 | CSF1R | 0.74228310 |
| 80 | TESK2 | 0.71950826 |
| 81 | TBK1 | 0.71867723 |
| 82 | SMG1 | 0.70755769 |
| 83 | KIT | 0.70501714 |
| 84 | BTK | 0.70357942 |
| 85 | PRKD2 | 0.70294718 |
| 86 | PRKD3 | 0.69538394 |
| 87 | DAPK3 | 0.66886283 |
| 88 | MAP2K3 | 0.65723251 |
| 89 | MAP3K11 | 0.63076514 |
| 90 | SGK3 | 0.61815968 |
| 91 | RPS6KA2 | 0.61731763 |
| 92 | MAPK7 | 0.61359137 |
| 93 | HCK | 0.60751706 |
| 94 | SGK2 | 0.60736751 |
| 95 | PRKCQ | 0.60109149 |
| 96 | CDC42BPA | 0.59997253 |
| 97 | STK11 | 0.59648776 |
| 98 | CAMK4 | 0.59594006 |
| 99 | YES1 | 0.59464343 |
| 100 | KSR1 | 0.59333804 |
| 101 | MATK | 0.57922680 |
| 102 | IKBKB | 0.57081474 |
| 103 | MAP3K6 | 0.56568014 |
| 104 | TYK2 | 0.54796047 |
| 105 | TEC | 0.53529129 |
| 106 | ITK | 0.53284386 |
| 107 | TGFBR2 | 0.53245911 |
| 108 | NLK | 0.53215757 |
| 109 | TXK | 0.53089688 |
| 110 | MAP3K10 | 0.52614246 |
| 111 | JAK1 | 0.52578537 |
| 112 | PTK2B | 0.52560868 |
| 113 | JAK2 | 0.52433144 |
| 114 | PRKG2 | 0.52377774 |
| 115 | LCK | 0.51933372 |
| 116 | CAMK1G | 0.51572199 |
| 117 | ERN1 | 0.50293533 |
| 118 | LMTK2 | 0.48716921 |
| 119 | PRKCZ | 0.48593832 |
| 120 | PRKCG | 0.47671506 |
| 121 | MAP2K1 | 0.46639693 |
| 122 | MAP2K2 | 0.46486031 |
| 123 | RPS6KC1 | 0.45616095 |
| 124 | RPS6KL1 | 0.45616095 |
| 125 | IRAK1 | 0.45308699 |
| 126 | FGFR4 | 0.44681103 |
| 127 | WNK1 | 0.42802972 |
| 128 | FYN | 0.42079272 |
| 129 | CAMK2A | 0.41882162 |
| 130 | PRKD1 | 0.40285672 |
| 131 | CAMK2G | 0.39815937 |
| 132 | BMX | 0.39402887 |
| 133 | LRRK2 | 0.37601883 |
| 134 | BMPR2 | 0.36624931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.78112757 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.59071353 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43003306 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.32224639 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23978364 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.23024541 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20725991 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.09984893 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09083574 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.05387557 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.04545379 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.02342681 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00349706 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.94634756 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.92012884 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90588326 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.88258453 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.79078186 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.77701619 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75618566 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74964501 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.69637358 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68367048 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.62685875 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62303231 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56307563 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54891996 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.54821999 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.45925749 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45101535 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.41392855 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40075364 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39632398 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.39163706 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38000831 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37100725 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35398552 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34880297 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34252032 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31575869 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31387970 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.28231286 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26549092 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.25686154 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25440822 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.23822815 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.21763741 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21556702 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19703220 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19249779 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18844104 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16956547 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15050572 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 1.10294249 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09276112 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.09200945 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08329010 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 1.07568255 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06630364 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04969504 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04503542 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03865522 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03305888 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02680436 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01506356 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01263630 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97684956 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96179548 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95683888 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95432155 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95268884 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94318205 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94300046 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93764599 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92287136 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92190427 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89772368 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89434410 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.89308315 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.88839592 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.87454271 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87393513 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87086427 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84777720 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.84229718 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.82871874 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80883670 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80062298 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79771380 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.79024329 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77598593 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77564693 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77278707 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.76284194 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75816118 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75101284 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.72374449 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72238039 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.72175683 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.72106833 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71387808 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70740170 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70599145 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70061839 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69539023 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.69348178 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68547548 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68149738 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67207146 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66464152 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66388150 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65413622 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.65211710 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.64277851 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63817334 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63208045 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61136725 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60999851 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59463627 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59060768 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55486171 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53138370 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52658023 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52350357 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52316790 |
| 126 | Phototransduction_Homo sapiens_hsa04744 | 0.51879328 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51842748 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50659891 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49158581 |
| 130 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48854604 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.46491608 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46282237 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44915725 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44121265 |
| 135 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43418714 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42831758 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41981370 |
| 138 | Tuberculosis_Homo sapiens_hsa05152 | 0.40376191 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38278664 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37855018 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.37680826 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37165019 |

